欢迎访问《标记免疫分析与临床》官方网站!
综述

肺癌早期诊断标志物研究进展

  • SHEN Di ,
  • QI Jun
展开
  • 北京协和医学院中国医学科学院肿瘤医院/肿瘤研究所,北京 100021
沈迪(1983-),女,在读硕士,主治医师,从事临床检验诊断工作。Tel:010-87788746; E-mail:sweetsmile976@sohu.com.

网络出版日期: 2013-11-01

Research Development of Blood Tumor Marker in Early Diagnosis of Lung Cancer

  • 沈 迪,齐 军
Expand
  • Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 10021, China

Online published: 2013-11-01

摘要

肺癌已成为绝大多数国家主要癌症死亡原因,早期诊断和早期治疗尤为重要。肺癌的发生是多因素致病、多基因参与和多阶段发展的复杂过程,近年来国内外学者对有关肺癌早期诊断的分子标志物做了大量有益的探索。本文将近年来肺癌早期实验室诊断的方法及进展做一综述。

关键词: 肺癌; 早期诊断; 标志物

本文引用格式

SHEN Di , QI Jun . 肺癌早期诊断标志物研究进展[J]. 标记免疫分析与临床, 2013 , 20(5) : 336 -347 . DOI: 10.11748/bjmy.issn.1006-1703.2013.05.017

Abstract

 Lung cancer is the most common cause of cancer death worldwide. Early diagnosis and early treatment are of great importance. Lung cancer is a multi-factorial disease, and multiple genes involved in the development of complex multi-stage process. In recent years, domestic and foreign scholars on the early diagnosis of lung cancer biomarkers have done a lot of useful exploration. In this paper, recent developments in this field are reviewed.

文章导航

/